To access the full text documents, please follow this link: http://hdl.handle.net/2445/108545
| dc.contributor.author | Grande, Iria |
|---|---|
| dc.contributor.author | Bernardo Arroyo, Miquel |
| dc.contributor.author | Bobes García, Julio |
| dc.contributor.author | Sainz-Ruiz, Jerónimo |
| dc.contributor.author | Álamo, Cecilio |
| dc.contributor.author | Vieta i Pascual, Eduard, 1963- |
| dc.date | 2017-03-17T09:02:03Z |
| dc.date | 2017-03-17T09:02:03Z |
| dc.date | 2013-03-21 |
| dc.date | 2017-03-17T09:02:03Z |
| dc.identifier | 1461-1457 |
| dc.identifier | 636927 |
| dc.identifier | 24139622 |
| dc.identifier.uri | http://hdl.handle.net/2445/108545 |
| dc.description | With the increasingly widespread use of antipsychotics in bipolar disorder (BD), switching among these agents and between antipsychotics and mood stabilizers has become more common, in particular, since the introduction of the novel atypical antipsychotics with mood stabilizer properties. This systematic review aims to provide a comprehensive update of the current literature in BD about the switching of antipsychotics, among them and between them and mood stabilizers, in acute and maintenance treatment. We conducted a comprehensive, computerized literature search using terms related to antipsychotic switching in BD in the PubMed/Medline, PsycINFO, CINAHL database; the Cochrane Library and; the Clinicaltrials.gov web up to January 9th, 2013 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search returned 4160 articles. After excluding duplications, reviews, case reports and studies that did not fulfil the selection criteria, 8 studies were included. Not only have few articles on antipsychotic switching been published but also recruitment in most studies included mixed samples of patients. In general, antipsychotic switching, regardless of the route of drug administration, was well tolerated and no interference was shown in antipsychotic effectiveness during the interchange of drugs. Metabolic improvement was perceived when the switch involved antipsychotics with a low metabolic risk profile. The evidence-base for antipsychotic switching in BD is scant, and little controlled data is available. Switch from quetiapine to lithium and from risperidone to olanzapine has proven successful. Switching to antipsychotics with low metabolic risk had some positive impact on several safety measures. In stabilized patients, the plateau cross-taper switch may be preferred. PsycINFO, CINAHL database; the Cochrane Library and; the Clinicaltrials.gov web up to January 9th, 2013 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search returned 4160 articles. After excluding duplications, reviews, case reports and studies that did not fulfil the selection criteria, 8 studies were included. Not only have few articles on antipsychotic switching been published but also recruitment in most studies included mixed samples of patients. In general, antipsychotic switching, regardless of the route of drug administration, was well tolerated and no interference was shown in antipsychotic effectiveness during the interchange of drugs. Metabolic improvement was perceived when the switch involved antipsychotics with a low metabolic risk profile. The evidence-base for antipsychotic switching in BD is scant, and little controlled data is available. Switch from quetiapine to lithium and from risperidone to olanzapine has proven successful. Switching to antipsychotics with low metabolic risk had some positive impact on several safety measures. In stabilized patients, the plateau cross-taper switch may be preferred. |
| dc.format | 11 p. |
| dc.format | application/pdf |
| dc.language | eng |
| dc.publisher | Cambridge University Press |
| dc.relation | Reproducció del document publicat a: https://doi.org/10.1017/S1461145713001168 |
| dc.relation | International Journal of Neuropsychopharmacology, 2013, vol. 17, num. 3, p. 497-507 |
| dc.relation | https://doi.org/10.1017/S1461145713001168 |
| dc.rights | (c) CINP (Collegium Internationale Neuro-Psychopharmacologicum) , 2013 |
| dc.rights | info:eu-repo/semantics/openAccess |
| dc.subject | Antipsicòtics |
| dc.subject | Trastorn bipolar |
| dc.subject | Esquizofrènia |
| dc.subject | Bases de dades bibliogràfiques |
| dc.subject | Emocions |
| dc.subject | Antipsychotic drugs |
| dc.subject | Manic-depressive illness |
| dc.subject | Schizophrenia |
| dc.subject | Machine-readable bibliographic data |
| dc.subject | Emotions |
| dc.title | Antipsychotic switching in bipolar disorders: a systematic review. |
| dc.type | info:eu-repo/semantics/article |
| dc.type | info:eu-repo/semantics/publishedVersion |
Related documents
Other documents of the same author
Grande, Iria; Bernardo Arroyo, Miquel; Bobes, Julio; Sainz-Ruiz, Jerónimo; Álamo, Cecilio; Vieta i Pascual, Eduard, 1963-
Mezquida, Gisela; Savullich, George; García Álvarez, Leticia; Bobes García, Julio; Mané, Anna; Bernardo Arroyo, Miquel; Fernández Egea, Emilio; García Rizo, Clemente; García-Portilla González, María Paz, 1962-; Toll, Alba
Mezquida Mateos, Gisela; Savullich, George; García Álvarez, Leticia; Bobes García, Julio; Mané Santacana, Anna; Bernardo Arroyo, Miquel; Fernández Egea, Emilio; García Rizo, Clemente; García-Portilla González, María Paz, 1962-; Toll, Alba
Barcones Molero, Maria Fe; MacDowell, Karina S.; García-Bueno, Borja; Bioque Alcázar, Miquel; Gutiérrez-Galve, Leticia; González-Pinto, Ana; Parellada, Maria José; Bobes García, Julio; Bernardo Arroyo, Miquel; Lobo, Antonio; Leza, Juan C
Varo, Cristina; Murru, Andrea; Salagre, Estela; Jiménez, Esther; Solé, Brisa; Montejo, Laura; Carvalho, André F.; Stubbs, Brendon; Grande, Iria; Martínez-Arán, Anabel, 1971-; Vieta i Pascual, Eduard, 1963-; Reinares, Maria